APP and Alzheimer disease: Next, we investigated the Aβ(1–40) plaque formation and APP expression in the APP/PS1 groups to ensure these mice suffering a similar pathological process of AD and tested the Aβ(1–40) plaque formation and APP expression in the EGCG-treated APP/PS1 mice to verify the effect of EGCG treatment.